DATED 15 NOVEMBER 2021 SHANGHAI BIO-HEART BIOLOGICAL TECHNOLOGY CO., LTD.上海百心安生物技術股份有限公司 THE CONTROLLING SHAREHOLDER(named in Schedule 1) andHUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED HONG KONG UNDERWRITING AGREEMENT relating to a public offering...
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
http://www.bio-heart.com/resource/upload/article_file/16370280352415.pdfUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (4)
Alternatively, you can try searching for similar contracts:
